Match Document Document Title
7612115 Aqueous pharmaceutical compositions  
The present invention has an object to provide an antibacterial aqueous pharmaceutical composition and an aqueous pharmaceutical composition which have a sufficiently low gelation temperature even...
7612109 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes  
Water soluble iron carbohydrate complex obtainable from an aqueous solution of iron (III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous...
7601338 Antiplaque oral composition containing enzymes and cyclodextrins  
An antiplaque oral care composition having enhanced oral hygiene and organoleptic properties is provided. The composition contains an enzyme and a cyclodextrin. Papain and other proteolytic enzymes...
7592328 Natural cyclodextrin complexes  
The present invention is directed to the novel use of complexes of cyclodextrin. In particular the invention is directed to a complex of a cyclodextrin selected from the group consisting of α-CD,...
7589080 β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases  
Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided....
7579017 Physical mode of action pesticide  
A physical mode of action pesticide for application on plants and in soils, and methods of manufacture and application, comprising an active ingredient in the form of a polymer in a concentration...
7569557 Compositions of estrogen-cyclodextrin complexes  
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
7557094 Skin cream composition  
The present invention is related to compositions containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a β-cyclodextrin conjugated vitamin A. The...
7553482 Use of a phosphate adsorbent to combat vascular diseases  
The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and...
7550445 Aripiprazole complex formulation and method  
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin...
7498318 Food for diabetics  
Provided is a carbohydrate mixture comprising at least one modified carbohydrate from a base body and a carbohydrate residue coupled therewith. The base body concerned is either a digestible...
7494761 Cyclodextrin derivative, photoresist composition including the cyclodextrin derivative and method of forming a pattern using the photoresist composition  
A photoresist film is formed on an object layer of a semiconductor device by coating the object layer with a photoresist composition including about 7 percent to about 14 percent by weight of a...
7446101 Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems  
The present invention describes an improved commercial process for the production of carotenoid-cyclodextrin complexes and formulation of the complex for human ingestion. Complexation with...
7427605 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof  
The present application relates to inhibitors of ribonucleotide reductase subunit 2 (R2), and methods and compositions related to the R2 inhibitors. In certain embodiments, the R2 inhibitors...
7427412 Gel-based cosmetic composition  
The invention relates to cosmetic compositions comprising an elastic, non-rigid, porous support in which a low-viscosity, gellant-containing, single phase otherwise unstable cosmetic formulation...
7423028 Injectable pharmaceutical compositions comprising sodium diclofenac and β-cyclodextrin  
Injectable pharmaceutical compositions are described comprising sodium diclofenac, a β-cyclodextrin and a polysorbate, suitable for subcutaneous and intramuscular administration.
7423027 Methods of using gamma cyclodextrin to control blood glucose and insulin secretion  
Disclosed are methods of producing a blunted postprandial glycemic response in an individual, and/or reducing postprandial insulin secretion, said methods comprising administering to the individual...
7423026 Methylated cyclodextrin complexes  
The present invention is directed to novel complexes of cyclodextrin. In particular the invention is directed to a complex of a cyclodextrin selected from the group consisting of...
7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid  
The invention concerns a method for preparing compounds for interaction of an active substance hardly soluble in an aqueous medium with a porous support. The invention is characterized in that it...
7375096 Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network  
A method of preparing a supramolecular complex containing at least one therapeutic agent and a multi-dimensional polymer network is described. A supramolecular complex prepared by a method of the...
7348317 Aqueous compositions containing metronidazole  
An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a...
7320963 Methods and compositions for delivery of pharmaceutical agents  
Methods and compositions for delivering pharmaceutical agents into cells, in particular urothelial cells of the bladder, are provided. In the methods and compositions of the invention, a...
7285157 Air filter  
An air-filter for a circulating and/or recirculating air system using a filter medium containing a microbiologically effective amount of a polymeric biguanide or salt thereof. Also claimed is a...
7265099 Use of chemical chelators as reversal agents for drug-induced neuromuscular block  
The invention relates to the use of chemical chelators for the preparation of a medicament for the reversal of drug-induced neuromuscular block, to a kit for providing neuromuscular block and its...
7259153 Drug formulation and delivery using crystalline methylated cyclodextrins  
The present invention is directed to pharmaceutical compositions containing crystalline methylated cyclodextrins, which enhance the solubility of the pharmaceutically active agent or agents of the...
7256234 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices  
The present invention is directed to a hybridized polymer matrix, a method of making such, and products incorporating such a matrix. The hybridized polymer matrix comprises a solvent-free polymer...
7247653 Pharmaceutical composition  
The present invention relates to a pharmaceutical composition containing a cycloalkene compound, a salt thereof or a prodrug thereof, and a nonionic surfactant and/or a cyclodextrin derivative...
7226914 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections  
A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulphated polysaccharide,...
7202233 Alprazolam inclusion complexes and pharmaceutical compositions thereof  
A pharmaceutical composition an inclusion complex and methods for treating patients and preparing said complex disclosed for transmucosal delivery comprising an inclusion complex of (a) alprazolam...
7202232 Acrylonitrile derivatives for inflammation and immune-related uses  
What is claimed is a compound represented by the following structural formula: or a pharmaceutically acceptable salt, solvate or clathrate thereof. The variables for Structural Formula (I) are...
7202231 β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases  
Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided....
7199111 Aqueous ifosfamide compositions for parenteral administration and a process for their preparations  
The present invention provides aqueous Ifosfamide compositions and a process for their preparation, in which the compositions have a reduced toxicity over and above the concomitant use of the...
7196073 Imine-forming polysaccharide adjuvants and immunostimulants  
The present invention relates to polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells, conjugated to one or more compounds...
7189740 Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes  
Methods of treating, preventing and/or managing myclodysplastic syndromes are disclosed. Specific methods encompass the administration of an immunomodulatory compound, or a pharmaceutically...
7186702 Method of treating leishmaniasis using methyl-beta-cyclodextrin  
The present invention relates to a composition useful for the treatment of leishmaniasis said composition comprising pharmaceutically effective amount of methyl-beta-cyclodextrin, optionally...
7182941 Method for reducing malodor impression on inanimate surfaces comprising uncomplexed cyclodextrin  
Methods of treating an inanimate object or inanimate surface which has malodor impression to reduce the malodor impression comprise the step of contacting the inanimate object or inanimate surface...
7157446 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol  
A ras-farnesyltransferase inhibitor complex formed from a ras-farnesyltransferase inhibitor or a pharmaceutically acceptable salt thereof, a substituted cyclodextrin, and ethanol is provided. The...
7151091 Compositions and methods for preventing infection  
This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to prevent infection. The compositions of the invention can be used to reduce or...
7141555 Modafinil compound and cyclodextrin mixtures  
Mixtures of a modafinil compound with a cyclodextrin, methods for their use, and compositions thereof are disclosed, along with complexes comprising a modafinil compound and a cyclodextrin which...
7138387 Clear aqueous composition comprising propofol and hydroxypropyl-beta-cyclodextrin  
Sterile pharmaceutical stable autoclaved clear aqueous compositions of propofol (2,6-Diisopropyl phenol) suitable for parenteral administration are described. The compositions essentially consist...
7115587 Aripiprazole complex formulation and method  
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin...
7115586 Non-inclusion cyclodextrin complexes  
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
7105500 Process for the antimicrobial treatment of fiber materials  
A process for the antimicrobial treatment of fiber materials, comprising applying to the fiber material an inclusion complex of a fiber-reactive cyclodextrin derivative with an antimicrobial agent...
7091193 Therapeutic formulations  
Formulations comprising one or more epothilones together with a pharmaceutically acceptable carrier, in particular such pharmaceutical compositions suitable for oral administration of an epothilone.
7091192 Linear cyclodextrin copolymers  
Linear cyclodextrin copolymers and linear oxidized cyclodextrin copolymers containing an unoxidized and/or an oxidized cyclodextrin moiety integrated into the polymer backbone are described....
7084132 Artemisinins with improved stability and bioavailability for therapeutic drug development and application  
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation...
7067483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin  
Disclosed are pharmaceutical composition containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a...
7056901 Microgel particles for the delivery of bioactive materials  
Novel microgels, microparticles and related polymeric materials capable of delivering bioactive materials to cells for use as vaccines or therapeutic agents. The materials are made using a...
7052683 Composition to detoxify formaldehyde in gaseous state, in aqueous solutions, and to protect human cell lines against formaldehyde  
A chemical compound is disclosed herein for performing a complex enzymatic neutralization and fixation of formaldehyde, providing a method for instantaneous neutralization of formaldehyde vapors...
7034013 Formulations containing propofol and a sulfoalkyl ether cyclodextrin  
An injectable formulation of a sedative hypnotic drug, such as the anesthetic drug propofol, that is pharmaceutically stable and demonstrates a reduced incidence of pain upon injection. The...